NAFLD patients also had similar levels of IL-1β and IL-6 compared to healthy controls (7.63 ± 1.74 vs. 6.26 ± 2.76, p = 0.701 and 3.17 ± 0.04 vs. 3.14 ± 0.10, p = 0.648, respectively; Table 3). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.